NCT01231334

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 286 (actual)
• Sponsor: Allergan · Industry
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	Dapsone plus Adapalene	Dapsone (Aczone® Gel 5%) applied to entire face in the morning. Adapalene (Differin® 0.3% Gel)followed by Dapsone (Aczone® Gel 5%) applied to entire face in the evening. Daily treatment for 12 weeks.
DRUG	Clindamycin/benzoyl peroxide plus Adapalene	Clindamycin/benzoyl peroxide (Duac® Topical Gel)applied to entire face in the morning. Adapalene (Differin® 0.3% Gel) applied to entire face in the evening. Daily treatment for 12 weeks

Timeline

• Start date: 2010-08-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2010-11-01
• Last updated: 2012-07-27
• Results posted: 2012-07-27

Locations

1 site across 1 country: United States